WEBVTT - Special Episode: Hep B Stigma & Discrimination

0:00:43.159 --> 0:00:46.839
<v Speaker 1>Hi, I'm erin Welsh and this is this podcast will

0:00:46.920 --> 0:00:50.559
<v Speaker 1>kill you. As you may have already noticed, this is

0:00:50.680 --> 0:00:54.360
<v Speaker 1>not your typical t p w k Y episode. For one,

0:00:54.640 --> 0:00:58.040
<v Speaker 1>you didn't hear Aaron Alman Updike say and I'm Erin

0:00:58.040 --> 0:01:01.160
<v Speaker 1>Alman Updyke. But don't worry. She'll still be there for

0:01:01.240 --> 0:01:04.679
<v Speaker 1>all of our regular episodes, and you won't just be

0:01:04.760 --> 0:01:07.839
<v Speaker 1>hearing me ramble on all by myself in this episode.

0:01:08.200 --> 0:01:11.480
<v Speaker 1>I've got a friend joining me. So what exactly is

0:01:11.560 --> 0:01:14.839
<v Speaker 1>going on? Well? This is a bonus episode, the first

0:01:14.920 --> 0:01:17.640
<v Speaker 1>in what will be a mini series of bonus content

0:01:17.720 --> 0:01:20.440
<v Speaker 1>over the next few months. If you've listened to the

0:01:20.440 --> 0:01:24.160
<v Speaker 1>podcast before, you know that we love a deep, deep

0:01:24.240 --> 0:01:27.360
<v Speaker 1>dive on a topic. After all, that's basically what our

0:01:27.400 --> 0:01:30.399
<v Speaker 1>podcast does and why we started doing it. But you

0:01:30.520 --> 0:01:34.720
<v Speaker 1>also know that we can't always make that dive ourselves. Instead,

0:01:34.840 --> 0:01:37.440
<v Speaker 1>one of our favorite things to do is to get

0:01:37.480 --> 0:01:41.560
<v Speaker 1>someone else, an expert, to help us explore those dimensions

0:01:41.600 --> 0:01:44.360
<v Speaker 1>of a disease or a topic that we can't quite

0:01:44.400 --> 0:01:47.840
<v Speaker 1>reach on our own. Many of our episodes have featured

0:01:47.840 --> 0:01:51.160
<v Speaker 1>these expert interviews, and I always have so much fun

0:01:51.240 --> 0:01:54.520
<v Speaker 1>talking with them about their research and I get sad

0:01:54.560 --> 0:01:57.000
<v Speaker 1>when the interview is over because I feel like there's

0:01:57.040 --> 0:02:00.720
<v Speaker 1>still so much to discuss, especially about the expert themselves,

0:02:01.440 --> 0:02:05.120
<v Speaker 1>which brings me to the second aim of this bonus episode.

0:02:05.160 --> 0:02:07.720
<v Speaker 1>For a long time on the podcast, we've talked about

0:02:07.760 --> 0:02:11.440
<v Speaker 1>doing a career's episode where we discuss the unbelievable number

0:02:11.480 --> 0:02:13.960
<v Speaker 1>of different and exciting things that you can do in

0:02:13.960 --> 0:02:17.639
<v Speaker 1>public health. We get lots of emails and messages from

0:02:17.680 --> 0:02:21.120
<v Speaker 1>listeners asking what an epidemiologist does on a day to

0:02:21.200 --> 0:02:24.600
<v Speaker 1>day basis, or what the difference is between a Master's

0:02:24.600 --> 0:02:28.000
<v Speaker 1>of science and masters of public health, And frankly, I

0:02:28.040 --> 0:02:31.440
<v Speaker 1>feel like the world has maybe never been as interested

0:02:31.520 --> 0:02:34.040
<v Speaker 1>in what actually goes on in the wide world of

0:02:34.080 --> 0:02:37.440
<v Speaker 1>public health as they are these days. So we thought

0:02:37.440 --> 0:02:39.519
<v Speaker 1>it would be so much fun to try to get

0:02:39.520 --> 0:02:42.840
<v Speaker 1>a better sense of what this amorphous umbrella term of

0:02:42.880 --> 0:02:47.160
<v Speaker 1>public health really means. We envisioned this episode as covering

0:02:47.240 --> 0:02:52.200
<v Speaker 1>everything from how to choose a graduate program, disease ecology, epidemiology,

0:02:52.320 --> 0:02:57.320
<v Speaker 1>public policy, etc. To all of the many diverse opportunities

0:02:57.360 --> 0:02:59.720
<v Speaker 1>open to people who want to pursue a career in

0:02:59.680 --> 0:03:06.680
<v Speaker 1>public health. Conservation biologist, infectious disease physician, biostatistician, entomologist, clinical

0:03:06.720 --> 0:03:11.160
<v Speaker 1>trials researcher. But we pretty quickly realized that this couldn't

0:03:11.200 --> 0:03:14.679
<v Speaker 1>possibly be done in just one episode or just one

0:03:14.720 --> 0:03:18.720
<v Speaker 1>mini series. Even so, in these bonus episodes, I'm combining

0:03:18.800 --> 0:03:21.320
<v Speaker 1>my love of an even deeper dive on a topic

0:03:21.760 --> 0:03:24.960
<v Speaker 1>with my love of picking a public health expert's brain

0:03:25.160 --> 0:03:27.639
<v Speaker 1>on what it is they do and how they got

0:03:27.680 --> 0:03:30.960
<v Speaker 1>to be where they are. Graciously offering to be the

0:03:31.000 --> 0:03:34.120
<v Speaker 1>first to have their brain picked is doctor Sherry Cohen,

0:03:34.560 --> 0:03:38.080
<v Speaker 1>Senior Vice President of the Hepatitis Bee Foundation, which is

0:03:38.120 --> 0:03:41.800
<v Speaker 1>a nonprofit institution that is dedicated to finding a cure

0:03:41.840 --> 0:03:44.440
<v Speaker 1>for the virus and improving the lives of those already

0:03:44.440 --> 0:03:48.320
<v Speaker 1>affected by the disease. Last week, Aaron and I covered

0:03:48.440 --> 0:03:51.440
<v Speaker 1>the hepatitis B virus, and if you haven't listened to

0:03:51.480 --> 0:03:54.840
<v Speaker 1>that episode yet, you definitely should because it'll give you

0:03:54.880 --> 0:03:57.640
<v Speaker 1>a nice backdrop of knowledge about this virus and the

0:03:57.640 --> 0:04:01.920
<v Speaker 1>disease that it causes to recap Hepatitis B is an

0:04:02.000 --> 0:04:06.920
<v Speaker 1>extremely prevalent infection, with nearly three hundred million people around

0:04:06.920 --> 0:04:10.680
<v Speaker 1>the world chronically infected. The hepatitis B virus, which is

0:04:10.720 --> 0:04:14.560
<v Speaker 1>transmitted through blood and body fluids can cause an acute

0:04:14.720 --> 0:04:17.679
<v Speaker 1>or a chronic infection, and it can progress to severe

0:04:17.760 --> 0:04:21.160
<v Speaker 1>liver disease and liver cancer in some people. The good

0:04:21.200 --> 0:04:24.200
<v Speaker 1>news is that we do have both a vaccine as

0:04:24.240 --> 0:04:27.520
<v Speaker 1>well as anti viral treatment, but the bad news is that,

0:04:27.600 --> 0:04:31.080
<v Speaker 1>despite having these tools to help prevent and control the infection,

0:04:31.839 --> 0:04:35.440
<v Speaker 1>a million and a half people are newly infected every year.

0:04:36.160 --> 0:04:38.080
<v Speaker 1>Part of that might be due to the lack of

0:04:38.120 --> 0:04:42.280
<v Speaker 1>access to timely vaccination or treatment, but another big component

0:04:42.360 --> 0:04:45.279
<v Speaker 1>to this is the stigma and discrimination faced by many

0:04:45.360 --> 0:04:49.200
<v Speaker 1>people living with hepatitis B. As we discussed in our

0:04:49.240 --> 0:04:52.839
<v Speaker 1>regular season episode, the hepatitis B virus carries with it

0:04:52.920 --> 0:04:56.599
<v Speaker 1>a substantial amount of stigma and discrimination, which can take

0:04:56.640 --> 0:04:59.160
<v Speaker 1>a large emotional and mental toll on someone who may

0:04:59.240 --> 0:05:02.760
<v Speaker 1>already be explos speriencing physical health challenges from their infection.

0:05:03.800 --> 0:05:08.080
<v Speaker 1>But unlike screening for antibodies or examining liver function numbers,

0:05:08.520 --> 0:05:11.360
<v Speaker 1>the impact of stigma is much more difficult to measure.

0:05:12.080 --> 0:05:15.080
<v Speaker 1>In this episode, I'll be asking doctor Cohen to fill

0:05:15.160 --> 0:05:18.039
<v Speaker 1>us in on what that stigma looks like, what is

0:05:18.080 --> 0:05:20.520
<v Speaker 1>being done about it, and what it's like to run

0:05:20.560 --> 0:05:24.040
<v Speaker 1>a public health nonprofit. I had such a great time

0:05:24.120 --> 0:05:27.080
<v Speaker 1>chatting with doctor Cohen and I learned so so much.

0:05:27.839 --> 0:05:30.200
<v Speaker 1>I will let her introduce herself and get right to

0:05:30.240 --> 0:05:50.400
<v Speaker 1>the brain picking right after this break.

0:05:55.720 --> 0:05:58.720
<v Speaker 2>Hi, my name is doctor Sherry Cohen. I am senior

0:05:58.839 --> 0:06:01.720
<v Speaker 2>vice president at the Chase B Foundation and we are

0:06:01.760 --> 0:06:03.839
<v Speaker 2>located in Doylestown, Pennsylvania.

0:06:04.000 --> 0:06:06.640
<v Speaker 1>Wonderful. Thank you so much for taking the time to

0:06:06.720 --> 0:06:07.640
<v Speaker 1>chat with me today.

0:06:08.400 --> 0:06:10.279
<v Speaker 2>Thank you. I'm really excited to be here.

0:06:10.720 --> 0:06:10.920
<v Speaker 3>Well.

0:06:10.960 --> 0:06:14.880
<v Speaker 1>I am also very excited, especially to learn more about

0:06:14.960 --> 0:06:19.040
<v Speaker 1>stigma and discrimination in hepatitis B, because it's such an

0:06:19.040 --> 0:06:22.160
<v Speaker 1>important topic, as you know, and it's one that we

0:06:22.240 --> 0:06:26.480
<v Speaker 1>only touched briefly upon in our Hepatitis B episode. Over

0:06:26.520 --> 0:06:29.320
<v Speaker 1>the past couple of decades, we have made some pretty

0:06:29.320 --> 0:06:33.080
<v Speaker 1>substantial strides in reducing the global burden of hepatitis B

0:06:33.320 --> 0:06:36.760
<v Speaker 1>through prevention and treatment, but we still have a long

0:06:36.800 --> 0:06:39.760
<v Speaker 1>way to go, and there are several barriers that keep

0:06:39.800 --> 0:06:43.040
<v Speaker 1>these preventative tools from working, such as a lack of

0:06:43.080 --> 0:06:46.640
<v Speaker 1>timely access to vaccines or a lack of understanding about

0:06:46.640 --> 0:06:50.120
<v Speaker 1>the viruses transmission. But can you talk about the ways

0:06:50.160 --> 0:06:53.479
<v Speaker 1>that stigma can also contribute to the persistence of the

0:06:53.520 --> 0:06:54.839
<v Speaker 1>hepatitis B virus.

0:06:55.800 --> 0:06:58.800
<v Speaker 2>Absolutely, it's a great question, and stigma is a big

0:06:58.839 --> 0:07:03.359
<v Speaker 2>problem and one that is unfortunately a major barrier to

0:07:03.560 --> 0:07:07.080
<v Speaker 2>eliminating hepatitis BE around the world. What we have is

0:07:07.120 --> 0:07:11.960
<v Speaker 2>a misunderstood disease, and so hepatitis B is so common

0:07:12.440 --> 0:07:15.600
<v Speaker 2>that it chronic. Hepatitis B impacts three hundred million people.

0:07:15.920 --> 0:07:18.640
<v Speaker 2>Yet every person that has it, I think feels isolated

0:07:18.640 --> 0:07:22.360
<v Speaker 2>and alone because we don't talk about it. Because hepatitis

0:07:22.400 --> 0:07:25.160
<v Speaker 2>B is kind of a condition of the shadows, and

0:07:25.240 --> 0:07:27.600
<v Speaker 2>people are often afraid to talk about it, and they're

0:07:27.640 --> 0:07:31.440
<v Speaker 2>afraid when they have it, and I think that lends

0:07:31.480 --> 0:07:35.440
<v Speaker 2>itself to a situation where when people get hepatitis B,

0:07:36.040 --> 0:07:40.520
<v Speaker 2>they tend to self isolate because they're afraid of others

0:07:40.600 --> 0:07:43.560
<v Speaker 2>judging them. They're afraid that they may be discriminated against

0:07:43.640 --> 0:07:45.640
<v Speaker 2>because they have it, and so they keep it to

0:07:45.680 --> 0:07:48.040
<v Speaker 2>themselves and they kind of pull back a little bit

0:07:48.080 --> 0:07:51.440
<v Speaker 2>from family and friends in society. And then you also

0:07:51.560 --> 0:07:57.440
<v Speaker 2>have societal stigma where we might actually be promoting stigma

0:07:58.160 --> 0:08:03.120
<v Speaker 2>in communities. And so it's unfortunately a major barrier, and

0:08:03.240 --> 0:08:06.720
<v Speaker 2>I think some of it has to do with how

0:08:06.760 --> 0:08:09.880
<v Speaker 2>hepatitis B is transmitted in that it is an infectious disease,

0:08:09.920 --> 0:08:14.160
<v Speaker 2>and of course there's always stigma with infectious diseases, but

0:08:14.480 --> 0:08:17.920
<v Speaker 2>I also think hepatitis B has been around for you know,

0:08:18.080 --> 0:08:21.400
<v Speaker 2>hundreds or thousands of years, and what comes along with

0:08:21.440 --> 0:08:25.920
<v Speaker 2>that is these sort of deep, ingrained beliefs that are

0:08:25.960 --> 0:08:29.960
<v Speaker 2>passed down from generation to generation about hepatitis B, and

0:08:30.440 --> 0:08:35.880
<v Speaker 2>that also, I think has lent itself to deep misperceptions

0:08:36.360 --> 0:08:39.840
<v Speaker 2>about the virus and about how it's transmitted and about

0:08:39.840 --> 0:08:44.280
<v Speaker 2>how it's treated, and it serves, unfortunately, to promote fear,

0:08:44.320 --> 0:08:46.200
<v Speaker 2>which means that people don't want to get tested and

0:08:46.400 --> 0:08:47.920
<v Speaker 2>don't want to tell anyone when they have it.

0:08:48.559 --> 0:08:52.120
<v Speaker 1>Right, absolutely, Can you talk about some of what these

0:08:52.240 --> 0:08:55.959
<v Speaker 1>common misperceptions are around the hepatitis B virus?

0:08:56.800 --> 0:08:59.880
<v Speaker 2>Yes, absolutely, we hear. So. We've done quite a lot

0:08:59.880 --> 0:09:03.520
<v Speaker 2>of research among communities that are highly impacted by hepatitis B,

0:09:03.840 --> 0:09:08.800
<v Speaker 2>and worldwide that's frankly almost everyone, but in particular it's Asian, American,

0:09:09.000 --> 0:09:12.880
<v Speaker 2>Pacific Islander and African communities. And what we often hear

0:09:13.080 --> 0:09:16.680
<v Speaker 2>is that people think that hepatitis B is genetic. That's

0:09:16.720 --> 0:09:19.600
<v Speaker 2>a big one, because it is passed down from mother

0:09:19.679 --> 0:09:23.920
<v Speaker 2>to child during the blood exchange that happens at childbirth,

0:09:24.400 --> 0:09:27.120
<v Speaker 2>you often wind up with family trees that are highly

0:09:27.160 --> 0:09:30.280
<v Speaker 2>impacted by hepatitis B, where you'll see grandparents and parents

0:09:30.360 --> 0:09:33.319
<v Speaker 2>and kids and aunts and uncles and cousins impacted by it.

0:09:33.600 --> 0:09:36.760
<v Speaker 2>And so people think hepatites B is genetic and that

0:09:37.240 --> 0:09:40.120
<v Speaker 2>only families are impacted if they have weak genes, or

0:09:40.640 --> 0:09:43.719
<v Speaker 2>that something's wrong with the family because everybody has hepatiz B,

0:09:44.240 --> 0:09:47.920
<v Speaker 2>and so that definitely promotes stigma, and it makes it

0:09:47.960 --> 0:09:52.440
<v Speaker 2>makes families feel, frankly feel bad and makes people not

0:09:52.520 --> 0:09:55.160
<v Speaker 2>want to say that they've that they've been infected with

0:09:55.200 --> 0:09:56.800
<v Speaker 2>heptais B or that they've been diagnosed.

0:09:57.760 --> 0:10:02.200
<v Speaker 1>So stigma and discrimination are often discussed together sort of

0:10:02.240 --> 0:10:06.280
<v Speaker 1>in just lumped together, but they represent these separate things, right, So,

0:10:06.440 --> 0:10:09.160
<v Speaker 1>in the case of hepatitis B, stigma is when someone

0:10:09.200 --> 0:10:12.880
<v Speaker 1>sees you negatively because of your diagnosis or you see

0:10:12.920 --> 0:10:17.320
<v Speaker 1>yourself negatively self stigma, while discrimination is when someone treats

0:10:17.320 --> 0:10:21.200
<v Speaker 1>you differently because of it. What do stigma and discrimination

0:10:21.360 --> 0:10:24.200
<v Speaker 1>look like for people with hepatitis B and why is

0:10:24.240 --> 0:10:27.040
<v Speaker 1>it important to make a distinction between the two.

0:10:27.960 --> 0:10:30.360
<v Speaker 2>Oh, I'm so glad you're distinguishing them. I think a

0:10:30.360 --> 0:10:33.199
<v Speaker 2>lot of times we lump them together, and it's really

0:10:33.200 --> 0:10:36.640
<v Speaker 2>important to understand the differences, and you defined it really,

0:10:36.880 --> 0:10:41.360
<v Speaker 2>really well. So I think when people feel stigmatized because

0:10:41.400 --> 0:10:44.880
<v Speaker 2>of hepatitis BE, whether it's self stigma or stigma that's

0:10:44.920 --> 0:10:48.640
<v Speaker 2>coming from external sources, it means that they pull apart.

0:10:48.679 --> 0:10:53.040
<v Speaker 2>So we often see people maybe a family where one

0:10:53.080 --> 0:10:55.960
<v Speaker 2>person has hepatitis BE and they're not allowed to eat

0:10:55.960 --> 0:10:58.640
<v Speaker 2>with the rest of the family, or they don't share

0:10:58.679 --> 0:11:02.920
<v Speaker 2>the family meals shared goals for example. We do see

0:11:02.920 --> 0:11:05.880
<v Speaker 2>that quite a bit, where families sometimes will shun people

0:11:05.880 --> 0:11:08.800
<v Speaker 2>who have hepatitis BE, or where we see a lot

0:11:08.840 --> 0:11:11.839
<v Speaker 2>of times people who are really concerned about transmitting the

0:11:11.920 --> 0:11:15.640
<v Speaker 2>virus where they will pull back. And so you'll see

0:11:15.679 --> 0:11:18.640
<v Speaker 2>people who they don't go out with their friends very much,

0:11:18.840 --> 0:11:22.600
<v Speaker 2>they are scared to date, so it impacts their relationships.

0:11:23.000 --> 0:11:25.840
<v Speaker 2>They may not go for a specific job because they're

0:11:25.880 --> 0:11:27.920
<v Speaker 2>afraid that they'll put others at risk, or afraid that

0:11:27.960 --> 0:11:29.800
<v Speaker 2>they won't be able to handle it in case they

0:11:29.800 --> 0:11:32.440
<v Speaker 2>start having symptoms or they don't feel good, and so

0:11:33.200 --> 0:11:37.080
<v Speaker 2>it does. It really impacts people's emotional life and their

0:11:37.160 --> 0:11:40.080
<v Speaker 2>social life as well as their professional life. So the

0:11:40.120 --> 0:11:44.080
<v Speaker 2>impacts of stigma are great, and one of the ways

0:11:44.080 --> 0:11:45.800
<v Speaker 2>that we're trying to get around that is just to

0:11:45.840 --> 0:11:47.560
<v Speaker 2>get people to talk about it more. You know, the

0:11:47.640 --> 0:11:51.200
<v Speaker 2>more people can talk about their experiences and the more

0:11:51.280 --> 0:11:55.480
<v Speaker 2>that we as communities can see people just like us

0:11:55.920 --> 0:11:58.920
<v Speaker 2>talk about their hepatitis B, I think it will help,

0:11:59.320 --> 0:12:00.520
<v Speaker 2>It will help to o it up.

0:12:01.280 --> 0:12:05.040
<v Speaker 1>Yeah, I'm so glad that you brought up this storytelling aspect,

0:12:05.120 --> 0:12:06.880
<v Speaker 1>and that's one of the things that I really love

0:12:07.240 --> 0:12:11.840
<v Speaker 1>that the Hepatitis B Foundation does is fighting stigma through storytelling.

0:12:12.160 --> 0:12:14.600
<v Speaker 1>So can you talk a little bit more about how

0:12:14.640 --> 0:12:18.880
<v Speaker 1>important storytelling is and what these storytelling events are like.

0:12:19.040 --> 0:12:21.600
<v Speaker 1>And also I think there's one coming up, is that right?

0:12:22.440 --> 0:12:24.960
<v Speaker 2>Yeah, we do have our next training session. So yeah.

0:12:25.000 --> 0:12:28.600
<v Speaker 2>So storytelling is it's part of the Almost every culture

0:12:28.679 --> 0:12:31.160
<v Speaker 2>has an aspect of storytelling to it. So when you

0:12:31.200 --> 0:12:36.280
<v Speaker 2>think about how do you educate people to overcome myths

0:12:36.360 --> 0:12:40.040
<v Speaker 2>and misperceptions and try and promote screening and get people

0:12:40.080 --> 0:12:42.280
<v Speaker 2>to get tested and get people to see their doctor

0:12:42.320 --> 0:12:45.720
<v Speaker 2>and get into care, well, you know brochures. You know,

0:12:45.760 --> 0:12:47.959
<v Speaker 2>we've done all kinds of things in public health over

0:12:48.000 --> 0:12:52.000
<v Speaker 2>the past decade number of decades. Brochures and websites and

0:12:52.040 --> 0:12:55.480
<v Speaker 2>things like that, they don't necessarily cut it. But when

0:12:55.520 --> 0:12:57.880
<v Speaker 2>you have stories, when you have people who have been

0:12:57.920 --> 0:13:00.920
<v Speaker 2>impacted by hepatitis B talking about how it has affected

0:13:00.920 --> 0:13:04.040
<v Speaker 2>their life and how they've overcome issues and what they're

0:13:04.080 --> 0:13:07.840
<v Speaker 2>dealing with, that is incredibly powerful. And it actually can

0:13:08.200 --> 0:13:11.760
<v Speaker 2>change people's perceptions, and it can promote people to get

0:13:11.800 --> 0:13:14.520
<v Speaker 2>tested and or it can promote them to stop feeling

0:13:14.559 --> 0:13:17.360
<v Speaker 2>bad maybe and to stop self isolating, or maybe it

0:13:17.400 --> 0:13:20.840
<v Speaker 2>will promote a healthcare provider to look differently at their

0:13:20.960 --> 0:13:25.280
<v Speaker 2>heptized be patients or their community. So storytelling, we think

0:13:25.360 --> 0:13:29.240
<v Speaker 2>is very, very impactful. We do have about forty storytellers

0:13:29.280 --> 0:13:33.320
<v Speaker 2>around the country. Our storytelling videos which are three minutes

0:13:33.360 --> 0:13:35.560
<v Speaker 2>long and they're in I think they're in nine languages.

0:13:35.600 --> 0:13:39.880
<v Speaker 2>Now they've been viewed almost three million times online and

0:13:39.920 --> 0:13:42.959
<v Speaker 2>so we're able to use technology to get the word out,

0:13:42.960 --> 0:13:45.839
<v Speaker 2>which is which I also think is very powerful. And

0:13:45.880 --> 0:13:47.840
<v Speaker 2>we do have a workshop coming up, so we work

0:13:47.880 --> 0:13:51.040
<v Speaker 2>with our storytellers and we train them on how to

0:13:51.080 --> 0:13:54.920
<v Speaker 2>most effectively and impactly tell their stories, and then we

0:13:55.040 --> 0:13:58.679
<v Speaker 2>help them, we connect them with ways to share their stories,

0:13:58.720 --> 0:14:02.920
<v Speaker 2>whether it's giving testimony at the FDA, or working to

0:14:03.000 --> 0:14:06.240
<v Speaker 2>write an article with a newspaper or a blog, or

0:14:06.360 --> 0:14:09.000
<v Speaker 2>we've had folks do Facebook lives. I mean, it's they're

0:14:09.160 --> 0:14:13.480
<v Speaker 2>incredible and very very dedicated. And we also have some

0:14:13.559 --> 0:14:18.080
<v Speaker 2>of our storytellers share stories specifically about their discrimination experiences,

0:14:18.120 --> 0:14:22.280
<v Speaker 2>which is very very important too. And I think outside

0:14:22.320 --> 0:14:25.760
<v Speaker 2>of stigma, what we tend to see around the country

0:14:25.880 --> 0:14:28.600
<v Speaker 2>or around the world where there are no protections in

0:14:28.640 --> 0:14:32.080
<v Speaker 2>place for people who have B, is that we see

0:14:32.120 --> 0:14:35.640
<v Speaker 2>policies that are discriminatory. So in many countries around the world,

0:14:36.040 --> 0:14:38.520
<v Speaker 2>if you have been diagnosed with Hepataties B, you can't

0:14:38.520 --> 0:14:42.080
<v Speaker 2>get a job, or you can't work in a certain industry,

0:14:42.720 --> 0:14:45.240
<v Speaker 2>or you can't immigrate. There are certain countries that won't

0:14:45.320 --> 0:14:47.800
<v Speaker 2>let you in if you test positive for Hepataties B,

0:14:48.560 --> 0:14:53.640
<v Speaker 2>and so discrimination is real and it impacts millions of lives.

0:14:53.960 --> 0:14:56.280
<v Speaker 2>I mean, in the US, we are very lucky. We

0:14:57.080 --> 0:15:00.600
<v Speaker 2>Hepatized B Foundation actually was at the forefront of working

0:15:00.680 --> 0:15:03.000
<v Speaker 2>to make sure that people who have B in the

0:15:03.080 --> 0:15:06.880
<v Speaker 2>US are protected and actually are now included under the

0:15:06.960 --> 0:15:10.600
<v Speaker 2>Americans with Disabilities Act. So you cannot discriminate against someone

0:15:10.600 --> 0:15:13.400
<v Speaker 2>who has hepatizes B in the US. That doesn't mean

0:15:13.440 --> 0:15:15.520
<v Speaker 2>it doesn't happen. It just means that technically you're not

0:15:15.520 --> 0:15:18.200
<v Speaker 2>supposed to do it. But around the world people don't

0:15:18.200 --> 0:15:21.000
<v Speaker 2>have those same protections, and I think it becomes very

0:15:21.040 --> 0:15:23.920
<v Speaker 2>difficult because if you're a person living with hepatitis B,

0:15:24.120 --> 0:15:26.920
<v Speaker 2>all of a sudden, you know B, and the possibility

0:15:26.920 --> 0:15:29.520
<v Speaker 2>of developing liver cancer is not your first concern. It's

0:15:29.520 --> 0:15:31.600
<v Speaker 2>putting food on the table because you can't get a job.

0:15:32.520 --> 0:15:35.480
<v Speaker 1>Right. No, that's such a good point, and I think

0:15:35.520 --> 0:15:39.040
<v Speaker 1>you brought up this really also crucially important point earlier too,

0:15:39.200 --> 0:15:43.760
<v Speaker 1>that although hepatitis B is a globally extremely prevalent disease,

0:15:44.160 --> 0:15:47.880
<v Speaker 1>the virus is not equally distributed around the world. And

0:15:48.160 --> 0:15:50.760
<v Speaker 1>so can you talk about some of the drivers of

0:15:50.800 --> 0:15:54.520
<v Speaker 1>those global disparities and hepatitis BE prevalence, maybe they're historical

0:15:54.600 --> 0:15:59.360
<v Speaker 1>drivers or current drivers, and how perception of hepatitis be

0:15:59.720 --> 0:16:03.560
<v Speaker 1>very around the world, not just in these discrimination or

0:16:03.640 --> 0:16:06.560
<v Speaker 1>lack of protection, but also in the way that people

0:16:06.680 --> 0:16:08.680
<v Speaker 1>view like stigma in hepatitis B.

0:16:09.560 --> 0:16:12.360
<v Speaker 2>Yeah, that's a great question. We do. See, we've done

0:16:12.440 --> 0:16:14.240
<v Speaker 2>We're doing some research on this now, and we do

0:16:14.280 --> 0:16:17.560
<v Speaker 2>see stigma differ and perceptions differ around the world. So

0:16:17.600 --> 0:16:21.120
<v Speaker 2>I think historically the driver has been the virus itself.

0:16:21.160 --> 0:16:23.920
<v Speaker 2>It is an ancient virus, and so when you have

0:16:24.280 --> 0:16:27.120
<v Speaker 2>communities and cultures that have been around for a very

0:16:27.160 --> 0:16:29.600
<v Speaker 2>long time, you're just going to see more hepatitis be there.

0:16:30.040 --> 0:16:33.960
<v Speaker 2>I think more modern drivers is vaccine access. I mean

0:16:33.960 --> 0:16:37.080
<v Speaker 2>that that is a really big issue. In areas of

0:16:37.120 --> 0:16:40.880
<v Speaker 2>the world where we've been able to implement universal vaccination

0:16:41.160 --> 0:16:44.560
<v Speaker 2>among babies when they're born, you're able to actually stop

0:16:44.640 --> 0:16:49.360
<v Speaker 2>the transmission to future generations. And so some places around

0:16:49.360 --> 0:16:52.640
<v Speaker 2>the world do better with vaccine and have implemented good

0:16:52.720 --> 0:16:55.720
<v Speaker 2>vaccine programs for twenty or thirty years. In some areas,

0:16:56.040 --> 0:16:59.200
<v Speaker 2>you know, implementing vaccination universally is a bigger challenge, and

0:16:59.280 --> 0:17:02.280
<v Speaker 2>so you can't stop the spread there. The birth dose

0:17:02.400 --> 0:17:05.480
<v Speaker 2>is critical. We have the capacity to stop every single

0:17:05.520 --> 0:17:07.560
<v Speaker 2>infection of hepatiz B in the world. We can make

0:17:07.600 --> 0:17:10.439
<v Speaker 2>it so that no baby is ever infected with hepatized B. Again,

0:17:10.640 --> 0:17:13.520
<v Speaker 2>it's just that we don't prioritize it right. So, you know,

0:17:13.680 --> 0:17:18.000
<v Speaker 2>childhood infin vaccination is incredibly important. No one misses when

0:17:18.119 --> 0:17:21.520
<v Speaker 2>possible a polio vaccine, for example. For some reason, the

0:17:21.560 --> 0:17:25.280
<v Speaker 2>same kind of priority and importance isn't given to making

0:17:25.280 --> 0:17:27.000
<v Speaker 2>sure that babies are protected from hepatiz B.

0:17:27.680 --> 0:17:30.920
<v Speaker 1>So, as you mentioned, there are nearly three hundred million

0:17:30.960 --> 0:17:34.720
<v Speaker 1>people around the world living with chronic hepatitis B, but

0:17:34.840 --> 0:17:38.520
<v Speaker 1>this disease receives so much less attention compared to other

0:17:38.600 --> 0:17:42.600
<v Speaker 1>diseases with similarly high or not even as high global prevalences.

0:17:43.080 --> 0:17:45.760
<v Speaker 1>So can you share your thoughts on why it seems

0:17:45.800 --> 0:17:49.560
<v Speaker 1>to be overlooked and how that's reflected also in funding

0:17:49.640 --> 0:17:51.480
<v Speaker 1>rates for research into this virus.

0:17:52.400 --> 0:17:55.080
<v Speaker 2>Absolutely, I think a lot of it has to do with,

0:17:55.720 --> 0:17:59.240
<v Speaker 2>again the communities that are impacted by hepatizes B and

0:17:59.280 --> 0:18:04.080
<v Speaker 2>the fact that it's stigmatized. We don't, unfortunately have a

0:18:04.160 --> 0:18:07.639
<v Speaker 2>really strong advocacy for voice Globally. People are not demanding

0:18:07.840 --> 0:18:11.000
<v Speaker 2>that they give access to vaccines and that governments are

0:18:11.040 --> 0:18:13.800
<v Speaker 2>giving access to treatments because they're afraid to speak out.

0:18:14.240 --> 0:18:16.240
<v Speaker 2>But outside of that, I think the fact that we

0:18:16.359 --> 0:18:19.560
<v Speaker 2>don't have a cure is a really big issue. You know,

0:18:20.000 --> 0:18:22.760
<v Speaker 2>our colleagues in the hepatitis sea world, who we work

0:18:22.760 --> 0:18:25.560
<v Speaker 2>with very closely they have a cure for hepatatus C,

0:18:26.119 --> 0:18:28.879
<v Speaker 2>and they have faced tons of challenges in terms of

0:18:28.920 --> 0:18:33.440
<v Speaker 2>access and getting governments and funders to prioritize that. Once

0:18:33.520 --> 0:18:36.320
<v Speaker 2>they found a cure for hepatatus C, it really did

0:18:36.320 --> 0:18:39.679
<v Speaker 2>become priority. And you can see countries and governments paying

0:18:40.119 --> 0:18:44.480
<v Speaker 2>for hepsy cure and governments that are actually implementing hepatitis

0:18:44.520 --> 0:18:46.920
<v Speaker 2>CE elimination plans. They're getting rid of all heps in

0:18:46.960 --> 0:18:50.560
<v Speaker 2>their country. And it's wonderful. If we had a cure

0:18:50.600 --> 0:18:53.040
<v Speaker 2>for hepatatis B, I suspect and I hope that we

0:18:53.080 --> 0:18:55.679
<v Speaker 2>would see the same kind of excitement. I think the

0:18:55.680 --> 0:18:57.560
<v Speaker 2>fact that we have really good treatment but not a

0:18:57.600 --> 0:19:00.960
<v Speaker 2>cure is holding us back. However, I'm not sure how

0:19:00.960 --> 0:19:03.480
<v Speaker 2>it's any different than HIV, right, so there's no cure

0:19:03.520 --> 0:19:06.760
<v Speaker 2>for HIV. In fact, treatment for HIV and treatment for

0:19:06.800 --> 0:19:10.720
<v Speaker 2>hept B are identical. You take antivirals forever essentially, and

0:19:11.160 --> 0:19:14.600
<v Speaker 2>yet we see, you know, huge uptake and push to

0:19:14.640 --> 0:19:17.920
<v Speaker 2>get everybody who is diagnosed with HIV on antivirals as

0:19:17.920 --> 0:19:20.680
<v Speaker 2>well they should. I'd like to see that same excitement

0:19:20.720 --> 0:19:23.120
<v Speaker 2>and prioritization to make sure that every person with hept

0:19:23.119 --> 0:19:26.840
<v Speaker 2>B gets their antivirals as well, and I just think,

0:19:27.320 --> 0:19:31.359
<v Speaker 2>you know, I'm not sure that people really understand the

0:19:31.400 --> 0:19:33.680
<v Speaker 2>link between het B and liver cancer and the fact

0:19:33.680 --> 0:19:36.240
<v Speaker 2>that one in four people with hepatized B will die

0:19:36.280 --> 0:19:39.040
<v Speaker 2>if they don't get treatment. I mean, that's huge and

0:19:39.440 --> 0:19:42.080
<v Speaker 2>if you've ever seen anyone die of liver cancer, it's awful.

0:19:42.560 --> 0:19:45.119
<v Speaker 2>And if you can prevent it, you know, you absolutely should.

0:19:45.119 --> 0:19:47.280
<v Speaker 2>But maybe we just aren't strong enough in our messaging.

0:19:48.000 --> 0:19:51.080
<v Speaker 1>What do you think is the challenge in getting a

0:19:51.160 --> 0:19:52.840
<v Speaker 1>cure for B?

0:19:54.040 --> 0:19:56.840
<v Speaker 2>Great question, and it is something we spend a lot

0:19:56.880 --> 0:20:00.320
<v Speaker 2>of time thinking about and talking about, I think as

0:20:00.960 --> 0:20:04.639
<v Speaker 2>public health scientists and as bench scientists. So, hepatized B

0:20:04.760 --> 0:20:06.639
<v Speaker 2>is a tricky virus, and one of the things that

0:20:06.640 --> 0:20:10.040
<v Speaker 2>the hepatized B virus does that other viruses don't do

0:20:10.280 --> 0:20:14.159
<v Speaker 2>is that integrates its DNA into the host genome. And

0:20:14.240 --> 0:20:17.520
<v Speaker 2>so once a person has that happen, it's really really

0:20:17.560 --> 0:20:20.040
<v Speaker 2>hard to get rid of. It's a it's a very

0:20:20.080 --> 0:20:24.200
<v Speaker 2>complicated virus, and you know, we've made great strides. There

0:20:24.240 --> 0:20:26.880
<v Speaker 2>are actually a number of drugs right now that are

0:20:26.880 --> 0:20:30.520
<v Speaker 2>in phase three clinical trial, and some people are cured

0:20:30.560 --> 0:20:33.240
<v Speaker 2>by the way their immune system just fights it off.

0:20:33.760 --> 0:20:35.720
<v Speaker 2>It's just that most people aren't able to do that.

0:20:35.800 --> 0:20:37.359
<v Speaker 2>And so what we have to figure out is for

0:20:37.400 --> 0:20:39.600
<v Speaker 2>those people who are able to fight the virus off

0:20:39.640 --> 0:20:41.520
<v Speaker 2>and be cured, you know, what is it that makes

0:20:41.560 --> 0:20:44.240
<v Speaker 2>them special? And how do how do we work with

0:20:44.680 --> 0:20:47.560
<v Speaker 2>targeting the virus and also boosting the immune system at

0:20:47.600 --> 0:20:50.600
<v Speaker 2>the same time to make sure that people can get

0:20:50.640 --> 0:20:54.040
<v Speaker 2>rid of the virus. I you know, I'm not unfortunately

0:20:54.600 --> 0:20:56.879
<v Speaker 2>a bench scientist is not my or an immunologist, it's

0:20:56.920 --> 0:20:59.439
<v Speaker 2>not my area. But my understanding is that it's just

0:20:59.480 --> 0:21:00.960
<v Speaker 2>a really tricky virus.

0:21:02.000 --> 0:21:05.080
<v Speaker 1>So, going back a bit to the discussion of stigma

0:21:05.119 --> 0:21:08.720
<v Speaker 1>and discrimination, you talked about the ways that we can

0:21:08.960 --> 0:21:11.000
<v Speaker 1>try to address those things or try to put in

0:21:11.040 --> 0:21:16.240
<v Speaker 1>place measures to protect against discrimination or storytelling as a

0:21:16.240 --> 0:21:21.040
<v Speaker 1>way to reduce stigma. How do we measure both the

0:21:21.080 --> 0:21:25.359
<v Speaker 1>impact of those types of programs, whether it's like to

0:21:25.400 --> 0:21:28.840
<v Speaker 1>reduce stigma and discrimination, and also how do we measure

0:21:29.520 --> 0:21:32.680
<v Speaker 1>the impact overall of stigma and discrimination? Like what does

0:21:32.680 --> 0:21:35.520
<v Speaker 1>that look like? What do those studies look like?

0:21:36.760 --> 0:21:39.480
<v Speaker 2>Great question, So I think and we we do quite

0:21:39.480 --> 0:21:41.560
<v Speaker 2>a lot of this now. Is measuring the impact and

0:21:41.600 --> 0:21:46.320
<v Speaker 2>a lot of that is done qualitatively, and so doing

0:21:46.400 --> 0:21:49.720
<v Speaker 2>things like focus groups and interviews, in depth interviews with

0:21:50.359 --> 0:21:53.040
<v Speaker 2>essentially hundreds of people living with hepatitis BE around the

0:21:53.080 --> 0:21:57.480
<v Speaker 2>world and asking really in depth questions, you are able

0:21:57.520 --> 0:22:02.040
<v Speaker 2>to tease out how stagma and discrimination impacts people with

0:22:02.119 --> 0:22:04.119
<v Speaker 2>hep B and then you publish on it, right And

0:22:04.200 --> 0:22:07.560
<v Speaker 2>so we've done that, working with people living with hept

0:22:07.600 --> 0:22:11.119
<v Speaker 2>B in multiple countries, in multiple languages, asking just really

0:22:11.160 --> 0:22:14.720
<v Speaker 2>asking them, how does hepatize be impact your life? And

0:22:14.760 --> 0:22:19.080
<v Speaker 2>we ask it from multiple perspectives, things like professional impact,

0:22:19.200 --> 0:22:22.919
<v Speaker 2>social impact, physical impact, psychological impact, and you're able to

0:22:23.080 --> 0:22:25.080
<v Speaker 2>do In doing that, you're able to tease out how

0:22:25.119 --> 0:22:28.840
<v Speaker 2>stigma and discrimination impacts people. You know, quantitative data collection

0:22:28.880 --> 0:22:31.720
<v Speaker 2>has a role too, and doing things like online surveys

0:22:32.320 --> 0:22:34.359
<v Speaker 2>you may not get as in depth information, but it

0:22:34.400 --> 0:22:37.520
<v Speaker 2>does give you a broad picture of perhaps how widespread

0:22:37.560 --> 0:22:40.960
<v Speaker 2>the issue is and how important it is in different

0:22:40.960 --> 0:22:44.760
<v Speaker 2>groups compared to others. And then I think in terms

0:22:44.800 --> 0:22:48.440
<v Speaker 2>of assessing impact of programs, you know, if you're trying

0:22:48.480 --> 0:22:52.639
<v Speaker 2>to impact discrimination, I think one of the keys to

0:22:52.720 --> 0:22:55.399
<v Speaker 2>look for is policy change. If you're able to change

0:22:55.440 --> 0:22:58.879
<v Speaker 2>policy at a governmental level, that's a huge win, and

0:22:58.920 --> 0:23:01.679
<v Speaker 2>that's a really nice way of knowing whether your program

0:23:01.720 --> 0:23:04.359
<v Speaker 2>or your project worked. But some of it is also

0:23:05.040 --> 0:23:08.640
<v Speaker 2>looking at your data. So we have a hotline, it's

0:23:08.720 --> 0:23:11.240
<v Speaker 2>essentially a helpline at the HEAB Foundation. We get about

0:23:11.240 --> 0:23:14.320
<v Speaker 2>ten thousand people contact us a year. We document every

0:23:14.359 --> 0:23:17.680
<v Speaker 2>single contact and what they're calling us about, so over

0:23:17.760 --> 0:23:20.600
<v Speaker 2>time you can see if less people are calling you

0:23:20.600 --> 0:23:24.040
<v Speaker 2>about stigma or discrimination. And for example, over the last

0:23:24.040 --> 0:23:26.320
<v Speaker 2>three years, we have seen a huge uptick in the

0:23:26.359 --> 0:23:29.880
<v Speaker 2>people who are reaching out to us about medication access

0:23:29.920 --> 0:23:33.040
<v Speaker 2>being able to forward their medications. So sometimes that's the

0:23:33.160 --> 0:23:36.280
<v Speaker 2>kind of data where it may not be as rigorous

0:23:36.359 --> 0:23:39.880
<v Speaker 2>as sort of quantitative data collection, but it does give

0:23:39.920 --> 0:23:42.000
<v Speaker 2>you a picture of what the needs are and how

0:23:42.040 --> 0:23:42.680
<v Speaker 2>they're changing.

0:23:43.320 --> 0:23:45.960
<v Speaker 1>Yeah, that's really interesting. I think it's like you said,

0:23:45.960 --> 0:23:49.560
<v Speaker 1>it takes so many different approaches to measure the impact.

0:23:50.080 --> 0:23:52.280
<v Speaker 1>And that kind of leads me into my next question,

0:23:52.440 --> 0:23:56.080
<v Speaker 1>which is sort of the million dollar question. What do

0:23:56.160 --> 0:23:59.840
<v Speaker 1>you think are our best tools to stop or reduce

0:24:00.080 --> 0:24:02.720
<v Speaker 1>stigma and discrimination when it comes to hepatitis B.

0:24:04.160 --> 0:24:06.639
<v Speaker 2>I think I think the power of the people you have.

0:24:06.880 --> 0:24:09.600
<v Speaker 2>Can you imagine if three hundred million people raise their voice.

0:24:09.680 --> 0:24:12.760
<v Speaker 2>I mean, it would be overpowering. I think that that's

0:24:12.800 --> 0:24:15.400
<v Speaker 2>our biggest strength. That we have three hundred million people

0:24:15.400 --> 0:24:18.119
<v Speaker 2>who are impacted with hepatitis B, and if we can

0:24:18.880 --> 0:24:23.240
<v Speaker 2>help even a small percentage of them to create a

0:24:23.280 --> 0:24:27.600
<v Speaker 2>grassroots advocacy movement and get people demanding that they have

0:24:27.720 --> 0:24:31.199
<v Speaker 2>access to hept BE testing and HEPTB treatment, that that

0:24:31.240 --> 0:24:32.159
<v Speaker 2>would be incredible.

0:24:32.920 --> 0:24:36.080
<v Speaker 1>So you've talked now about multiple different ways that the

0:24:36.080 --> 0:24:41.240
<v Speaker 1>Hepatitis B Foundation is addressing these issues of stigma and discrimination.

0:24:41.920 --> 0:24:44.320
<v Speaker 1>Can you talk a little bit more about the other

0:24:44.400 --> 0:24:46.359
<v Speaker 1>missions that the Foundation has.

0:24:47.040 --> 0:24:49.320
<v Speaker 2>So overall, our mission is to find a cure for

0:24:49.359 --> 0:24:51.800
<v Speaker 2>hepatitise B and to improve the quality of life of

0:24:51.840 --> 0:24:55.040
<v Speaker 2>everyone living with HEPTBE worldwide, and so I have to

0:24:55.080 --> 0:24:58.080
<v Speaker 2>mention our research arms. So we do have about fifty

0:24:58.160 --> 0:25:01.159
<v Speaker 2>inch scientists immunologists for all, just in chemists who are

0:25:01.200 --> 0:25:04.200
<v Speaker 2>working to find a cure for heptaise B, and they

0:25:04.240 --> 0:25:07.600
<v Speaker 2>are at our Biotechnology center in Doylestomp, Pennsylvania. In fact,

0:25:07.960 --> 0:25:10.600
<v Speaker 2>one of the great privileges of my life is that

0:25:10.760 --> 0:25:12.879
<v Speaker 2>as a public health scientist, I can walk down the

0:25:12.920 --> 0:25:16.320
<v Speaker 2>hall and speak with leading scientists who are who know

0:25:16.480 --> 0:25:19.000
<v Speaker 2>everything about the virus and are looking for a cure.

0:25:19.440 --> 0:25:21.600
<v Speaker 2>So we do do that, we fund that research, and

0:25:21.720 --> 0:25:25.160
<v Speaker 2>also I think from the public health perspective, I think

0:25:25.200 --> 0:25:28.160
<v Speaker 2>our biggest issue is getting the world ready for a cure,

0:25:28.280 --> 0:25:30.240
<v Speaker 2>at least that's how I see it. So if we

0:25:30.320 --> 0:25:33.560
<v Speaker 2>found a cure for hepatitis B tomorrow, and wouldn't that

0:25:33.560 --> 0:25:36.639
<v Speaker 2>be incredible, I'm not sure who would get it because

0:25:36.680 --> 0:25:40.040
<v Speaker 2>you have a situation where worldwide only about ten percent

0:25:40.119 --> 0:25:43.720
<v Speaker 2>of people are diagnosed with HEBB and even less access care.

0:25:44.080 --> 0:25:46.640
<v Speaker 2>And so my job and the job of the team

0:25:46.680 --> 0:25:48.760
<v Speaker 2>at the heap B Foundation is to get the world

0:25:48.840 --> 0:25:51.800
<v Speaker 2>ready so that when we have a cure and hopefully

0:25:51.880 --> 0:25:56.120
<v Speaker 2>a functional cure in five, ten, even fifteen years, everyone

0:25:56.160 --> 0:25:58.240
<v Speaker 2>who needs it can get it. And so we do

0:25:58.359 --> 0:26:01.399
<v Speaker 2>a lot of work figuring out what the challenges are,

0:26:01.720 --> 0:26:04.560
<v Speaker 2>what are the barriers to testing and care and treatment,

0:26:04.640 --> 0:26:07.520
<v Speaker 2>and then overcoming them, and that I think is the

0:26:07.520 --> 0:26:08.480
<v Speaker 2>big picture for us.

0:26:09.400 --> 0:26:11.720
<v Speaker 1>So we're going to take a quick break here and

0:26:11.760 --> 0:26:13.880
<v Speaker 1>then when we get back, I want to hear all

0:26:13.920 --> 0:26:17.040
<v Speaker 1>about how you got involved with this super cool, wonderful,

0:26:17.200 --> 0:26:18.200
<v Speaker 1>very important work.

0:26:18.640 --> 0:26:45.440
<v Speaker 4>Okay, welcome back everyone.

0:26:46.040 --> 0:26:48.840
<v Speaker 1>So in the first half of this interview, we learned

0:26:49.040 --> 0:26:52.840
<v Speaker 1>so so much about the impacts that stigma and discrimination

0:26:53.040 --> 0:26:56.720
<v Speaker 1>have on people living with hepatitis B. But now I

0:26:56.760 --> 0:26:59.320
<v Speaker 1>want to shift talking more about what it's like to

0:26:59.359 --> 0:27:03.200
<v Speaker 1>be involved with this type of work. So doctor Cohen,

0:27:03.760 --> 0:27:06.280
<v Speaker 1>can you start us off by talking a bit about

0:27:06.320 --> 0:27:09.400
<v Speaker 1>your job, Like how much does your job title actually

0:27:09.440 --> 0:27:11.600
<v Speaker 1>reflect what you end up doing on a day to

0:27:11.680 --> 0:27:12.320
<v Speaker 1>day basis.

0:27:12.920 --> 0:27:14.000
<v Speaker 2>That's a great question.

0:27:14.160 --> 0:27:19.880
<v Speaker 3>I have no idea, Okay, So I think in any

0:27:20.000 --> 0:27:23.720
<v Speaker 3>given day, I'm I do administration, right because I have

0:27:23.760 --> 0:27:24.800
<v Speaker 3>to run the organization.

0:27:24.880 --> 0:27:28.879
<v Speaker 2>So it's budgeting and grant writing and report writing, making

0:27:28.920 --> 0:27:31.440
<v Speaker 2>sure that my staff and the team have everything they

0:27:31.480 --> 0:27:34.720
<v Speaker 2>need to do their job, so you know, training and

0:27:34.800 --> 0:27:38.840
<v Speaker 2>administration and just checking in with people, and then of course,

0:27:39.200 --> 0:27:41.720
<v Speaker 2>you know, working on the programs themselves. And so I

0:27:42.240 --> 0:27:44.440
<v Speaker 2>try and do a little bit of research every day

0:27:44.480 --> 0:27:46.680
<v Speaker 2>if I can, just because it's it's what I love

0:27:46.720 --> 0:27:50.080
<v Speaker 2>to do. So doing a little bit of research, probably

0:27:50.160 --> 0:27:53.639
<v Speaker 2>a little grant writing, probably working on an article or

0:27:53.680 --> 0:27:58.880
<v Speaker 2>a public journal article or a publication, answering consults for people.

0:27:59.400 --> 0:28:02.000
<v Speaker 2>And right now, of course I'm the cod COVID nineteen

0:28:02.000 --> 0:28:04.040
<v Speaker 2>safety officer for our campus. So a lot of my

0:28:04.080 --> 0:28:07.119
<v Speaker 2>time right now is actually contact tracing and setting policies

0:28:07.200 --> 0:28:10.480
<v Speaker 2>for preventing the spread of COVID nineteen. So I don't

0:28:10.520 --> 0:28:15.959
<v Speaker 2>know how much my title reflects my job, but I

0:28:15.960 --> 0:28:19.560
<v Speaker 2>think perhaps my title is global enough that it does

0:28:19.600 --> 0:28:22.359
<v Speaker 2>reflect the fact that I think. And that's one of

0:28:22.400 --> 0:28:24.000
<v Speaker 2>the great things about public health. I think I do

0:28:24.040 --> 0:28:26.760
<v Speaker 2>twelve different things every day, some of that I like

0:28:26.840 --> 0:28:29.919
<v Speaker 2>more than others, but I do it all.

0:28:30.080 --> 0:28:32.200
<v Speaker 1>What are some of those things that you like more

0:28:32.240 --> 0:28:32.760
<v Speaker 1>than others?

0:28:33.440 --> 0:28:36.640
<v Speaker 2>All the research. I love doing the research, whether it's

0:28:36.720 --> 0:28:39.720
<v Speaker 2>qualitative research, and in fact, just today I was doing

0:28:39.920 --> 0:28:43.800
<v Speaker 2>I was working on some focus group analysis and absolutely

0:28:44.400 --> 0:28:46.120
<v Speaker 2>enjoyed it. In fact, I hated when I had to

0:28:46.160 --> 0:28:49.440
<v Speaker 2>stop it. I love working with the staff when we do,

0:28:49.600 --> 0:28:51.360
<v Speaker 2>like our team, when we get together and we do

0:28:51.400 --> 0:28:55.880
<v Speaker 2>strategic planning, or when we have a new exciting idea

0:28:56.080 --> 0:28:58.960
<v Speaker 2>that we want to flesh out, and I did that

0:28:59.000 --> 0:29:01.200
<v Speaker 2>this morning. In fact, so I was meeting with one

0:29:01.200 --> 0:29:04.080
<v Speaker 2>of the team members and we were talking about hepatitis

0:29:04.120 --> 0:29:07.040
<v Speaker 2>Delta and some exciting new program ideas for that this year.

0:29:07.240 --> 0:29:09.440
<v Speaker 2>So that part I love anything that has to do

0:29:09.480 --> 0:29:12.520
<v Speaker 2>with working with partners. I love, But of course for me,

0:29:12.560 --> 0:29:13.560
<v Speaker 2>it's all about the research.

0:29:14.280 --> 0:29:17.120
<v Speaker 1>So when you tell someone I work with hepatitis B

0:29:17.360 --> 0:29:20.840
<v Speaker 1>and I help run this nonprofit, what do you think

0:29:20.920 --> 0:29:23.800
<v Speaker 1>some of the aspects of your job that may not

0:29:24.040 --> 0:29:27.320
<v Speaker 1>come to someone's mind immediately when they hear that that's

0:29:27.360 --> 0:29:29.360
<v Speaker 1>what you do. Like, what do you think that they

0:29:29.400 --> 0:29:31.120
<v Speaker 1>would be surprised to learn that you do?

0:29:32.080 --> 0:29:36.320
<v Speaker 2>Oh? Wow, that's a great question. I think budgeting is

0:29:36.360 --> 0:29:39.680
<v Speaker 2>something you know, that we all have to do in

0:29:39.720 --> 0:29:42.600
<v Speaker 2>public health because you wind up getting grants or some

0:29:42.680 --> 0:29:44.840
<v Speaker 2>kind of funding for your programs and projects, and then

0:29:44.880 --> 0:29:47.080
<v Speaker 2>you have to so you have to kind of first

0:29:47.120 --> 0:29:48.680
<v Speaker 2>figure out how much you think you're going to spend

0:29:48.680 --> 0:29:51.080
<v Speaker 2>on something, and then and then actually spend it like

0:29:51.120 --> 0:29:53.480
<v Speaker 2>you said you were going to. So I do think

0:29:53.560 --> 0:29:56.240
<v Speaker 2>that's probably something people don't realize that we do a

0:29:56.240 --> 0:29:59.720
<v Speaker 2>lot of in public health. I also, I'm not sure

0:29:59.760 --> 0:30:03.240
<v Speaker 2>people understand the idea of, you know, all the different

0:30:03.280 --> 0:30:06.200
<v Speaker 2>ways that we have to try and get funding, So

0:30:06.320 --> 0:30:12.880
<v Speaker 2>grant writing and advocacy work and fundraising, event planning, I mean,

0:30:12.960 --> 0:30:15.560
<v Speaker 2>all of it goes into public health and you can't

0:30:15.600 --> 0:30:19.320
<v Speaker 2>do anything without it, you know. I think people today

0:30:19.520 --> 0:30:21.719
<v Speaker 2>have a little bit more of an idea of what

0:30:21.760 --> 0:30:24.200
<v Speaker 2>public health means than they may have a few years

0:30:24.240 --> 0:30:27.360
<v Speaker 2>ago because of the COVID nineteen pandemic. Although I think

0:30:28.200 --> 0:30:30.360
<v Speaker 2>when people think of public health right now, they may

0:30:30.400 --> 0:30:33.560
<v Speaker 2>think of epidemiology and not understand, you know, all the

0:30:33.720 --> 0:30:37.440
<v Speaker 2>thousands of other things that we do, like developing communications

0:30:37.480 --> 0:30:42.080
<v Speaker 2>campaigns to help people understand health issues. That's a big

0:30:42.120 --> 0:30:44.840
<v Speaker 2>part of it too, And people may not not understand.

0:30:44.360 --> 0:30:48.640
<v Speaker 1>That public health is such an enormous and difficult to

0:30:48.720 --> 0:30:52.600
<v Speaker 1>define field that there seems like endless things that you

0:30:52.640 --> 0:30:56.160
<v Speaker 1>can do, which is really cool. I mean, it's amazing.

0:30:56.920 --> 0:30:58.760
<v Speaker 2>Yeah, I agree, and it's one of the things that

0:30:58.800 --> 0:31:00.800
<v Speaker 2>attracted me to public health in the first place, I think,

0:31:00.920 --> 0:31:02.400
<v Speaker 2>was that there's just so much you can do.

0:31:03.040 --> 0:31:04.760
<v Speaker 1>Yeah. So, so talk to me a little bit more

0:31:04.760 --> 0:31:07.800
<v Speaker 1>about that. How did you get started in public health?

0:31:08.000 --> 0:31:10.920
<v Speaker 1>And you know, what was your journey from your early

0:31:11.000 --> 0:31:13.280
<v Speaker 1>days of your educational career all the way to how

0:31:13.320 --> 0:31:15.080
<v Speaker 1>you got involved in het B work.

0:31:15.840 --> 0:31:17.920
<v Speaker 2>Sure, So I think I I think I fell into

0:31:17.960 --> 0:31:21.320
<v Speaker 2>public health in a in a similar way to a

0:31:21.320 --> 0:31:23.760
<v Speaker 2>lot of other public health scientists. I was pre med

0:31:23.880 --> 0:31:26.480
<v Speaker 2>in undergrad and I really thought that I thought that

0:31:26.520 --> 0:31:28.479
<v Speaker 2>I was going to go to medical school. And so

0:31:28.640 --> 0:31:32.400
<v Speaker 2>after I graduated with my undergrad and with my bachelor's,

0:31:32.480 --> 0:31:35.840
<v Speaker 2>I took a year off and I did a fellowship

0:31:35.840 --> 0:31:37.920
<v Speaker 2>at the National Cancer Institute where I was. I worked

0:31:37.960 --> 0:31:40.680
<v Speaker 2>in a lab for a year and I really enjoyed it.

0:31:40.880 --> 0:31:44.040
<v Speaker 2>And while I was there, I took a public health

0:31:44.080 --> 0:31:48.200
<v Speaker 2>class at GW and I had no idea what public

0:31:48.280 --> 0:31:51.520
<v Speaker 2>health was and was still committed to med school. And

0:31:51.760 --> 0:31:55.160
<v Speaker 2>mann did I love that class, And so I just,

0:31:55.680 --> 0:31:59.560
<v Speaker 2>you know, I started thinking more about public health than

0:31:59.680 --> 0:32:03.880
<v Speaker 2>about medicine, and at some point what I wanted to

0:32:03.920 --> 0:32:07.080
<v Speaker 2>do just switched. I spent some time interviewing clinicians, and

0:32:07.120 --> 0:32:09.640
<v Speaker 2>I spent some time interviewing public health practitioners, and it

0:32:09.680 --> 0:32:13.080
<v Speaker 2>became clear to me over time that really that's where

0:32:13.080 --> 0:32:15.720
<v Speaker 2>my heart was. It was working in communities and not

0:32:15.800 --> 0:32:18.840
<v Speaker 2>working in a lab and not doing clinical work. So,

0:32:19.120 --> 0:32:21.800
<v Speaker 2>much to my parents chagrin, I gave up to the

0:32:21.880 --> 0:32:24.440
<v Speaker 2>idea of going to med school and I got my

0:32:24.560 --> 0:32:25.360
<v Speaker 2>MPH instead.

0:32:26.360 --> 0:32:28.960
<v Speaker 1>That's so fascinating. I feel like that story resonates with

0:32:28.960 --> 0:32:31.360
<v Speaker 1>a lot of people who only discover public health later

0:32:31.400 --> 0:32:33.520
<v Speaker 1>on or later than they thought they might have.

0:32:34.560 --> 0:32:36.520
<v Speaker 2>Yeah, I agree, And in fact, one of the things

0:32:36.560 --> 0:32:38.800
<v Speaker 2>I try and do so we do some education at

0:32:38.840 --> 0:32:41.640
<v Speaker 2>the foundation. We bring in high school students and college students,

0:32:41.680 --> 0:32:43.400
<v Speaker 2>and I always try and worm my way in and

0:32:43.800 --> 0:32:46.000
<v Speaker 2>let them know that public health is an option. Because

0:32:46.000 --> 0:32:48.800
<v Speaker 2>I think you're right. When you're young and you like science,

0:32:48.920 --> 0:32:50.760
<v Speaker 2>you think I'm going to go to I'm either going

0:32:50.800 --> 0:32:52.280
<v Speaker 2>to go to med school or I'm going to work

0:32:52.280 --> 0:32:55.240
<v Speaker 2>in a lab. And I think public health just doesn't

0:32:55.280 --> 0:32:59.240
<v Speaker 2>get enough. We don't promote it enough to young people,

0:32:59.440 --> 0:33:01.480
<v Speaker 2>because I do think that a lot of people would

0:33:01.680 --> 0:33:04.040
<v Speaker 2>would go for it. I think so when I when

0:33:04.080 --> 0:33:07.280
<v Speaker 2>I first made the switch, I was nervous myself. I

0:33:07.400 --> 0:33:11.720
<v Speaker 2>was thinking, I love science, love science. I'm a biology

0:33:12.000 --> 0:33:14.440
<v Speaker 2>you know, biology nerd, and I was worried that I

0:33:14.480 --> 0:33:16.560
<v Speaker 2>was going to have to give that up in public health.

0:33:16.600 --> 0:33:18.800
<v Speaker 2>And you really don't. I mean, I you know, if

0:33:18.840 --> 0:33:20.920
<v Speaker 2>you stay up on the science. I consider myself a

0:33:21.000 --> 0:33:24.440
<v Speaker 2>scientist and I stay up on the latest research. And

0:33:24.920 --> 0:33:26.840
<v Speaker 2>I don't think you have to give up science to

0:33:26.920 --> 0:33:28.840
<v Speaker 2>do public health, which I think a lot of people

0:33:28.880 --> 0:33:30.520
<v Speaker 2>don't don't understand.

0:33:30.480 --> 0:33:33.400
<v Speaker 1>Right absolutely, And and you know on that there are

0:33:33.400 --> 0:33:36.360
<v Speaker 1>so many different ways you can do public health or

0:33:36.400 --> 0:33:39.360
<v Speaker 1>do science in public health. You know, there's and Masters

0:33:39.400 --> 0:33:42.600
<v Speaker 1>of Science or an MPH Masters of public Health. There's

0:33:42.800 --> 0:33:45.200
<v Speaker 1>a Doctor of public Health and a PhD. There are

0:33:45.200 --> 0:33:48.960
<v Speaker 1>so many different degree options here. So can you share

0:33:48.960 --> 0:33:51.200
<v Speaker 1>a little bit about why you chose the different graduate

0:33:51.280 --> 0:33:52.479
<v Speaker 1>programs that you chose.

0:33:53.200 --> 0:33:57.840
<v Speaker 2>Absolutely so. I started with I chose the MPH program.

0:33:58.200 --> 0:34:00.640
<v Speaker 2>I got my master's in public health at Temple University.

0:34:00.680 --> 0:34:02.959
<v Speaker 2>We were living outside of Philly at the time, and

0:34:03.200 --> 0:34:07.600
<v Speaker 2>I really enjoyed the program. I like that it was applied.

0:34:08.120 --> 0:34:12.479
<v Speaker 2>I didn't necessarily see myself going into epidemiology or though

0:34:12.560 --> 0:34:15.840
<v Speaker 2>although I did concentrate in ep I liked concentrating in it,

0:34:15.880 --> 0:34:17.680
<v Speaker 2>but I didn't know that I wanted to practice EPI.

0:34:18.160 --> 0:34:21.080
<v Speaker 2>And I felt like the MPH gave me that flexibility

0:34:21.120 --> 0:34:22.919
<v Speaker 2>and they paid for me, which was the best part.

0:34:23.000 --> 0:34:25.040
<v Speaker 2>I got a teaching assistantship and they paid for my

0:34:25.200 --> 0:34:29.280
<v Speaker 2>masters which that of course, helped me make my choice.

0:34:29.800 --> 0:34:32.279
<v Speaker 2>I do think that that this is good advice. I

0:34:32.280 --> 0:34:34.560
<v Speaker 2>took time off in between getting my master's and my

0:34:34.680 --> 0:34:38.040
<v Speaker 2>doctorate and I worked for a while because I think

0:34:38.120 --> 0:34:41.919
<v Speaker 2>before you commit to a doctorate program, you should try

0:34:41.960 --> 0:34:44.640
<v Speaker 2>and work in the field and really think about what

0:34:44.680 --> 0:34:47.040
<v Speaker 2>it is you want to do. Because if you do

0:34:47.120 --> 0:34:49.680
<v Speaker 2>want to stay in academia and you want to practice

0:34:49.680 --> 0:34:53.440
<v Speaker 2>public health through an academic lens, then you know there

0:34:53.440 --> 0:34:56.040
<v Speaker 2>are PhD programs out there that are excellent, or you

0:34:56.040 --> 0:34:59.200
<v Speaker 2>can get your DrPH. But I will say a DrPH

0:34:59.239 --> 0:35:02.319
<v Speaker 2>a doctorate in public health is it is supposed to

0:35:02.320 --> 0:35:05.799
<v Speaker 2>be more of an applied degree, meaning it should give

0:35:05.840 --> 0:35:08.719
<v Speaker 2>you everything you need to go out and practice public health.

0:35:08.760 --> 0:35:10.640
<v Speaker 2>Not that you can't be in academics, because you could,

0:35:10.760 --> 0:35:12.560
<v Speaker 2>but it is meant to be more applied. And so

0:35:13.320 --> 0:35:17.000
<v Speaker 2>I do think I was lucky in that I took

0:35:17.040 --> 0:35:19.439
<v Speaker 2>some time off in between to decide what I wanted

0:35:19.480 --> 0:35:22.319
<v Speaker 2>to do and which degree I should get. When I

0:35:22.320 --> 0:35:25.720
<v Speaker 2>started in the doctor program, I could have gone two ways.

0:35:25.760 --> 0:35:28.920
<v Speaker 2>They had the epidemiology program and then the community health

0:35:28.920 --> 0:35:31.480
<v Speaker 2>and prevention program, and I was not sure which one

0:35:31.480 --> 0:35:33.719
<v Speaker 2>I was going to do. And this is where the

0:35:33.760 --> 0:35:37.160
<v Speaker 2>power of mentors come in. I had one of my

0:35:37.960 --> 0:35:40.640
<v Speaker 2>most amazing mentors. His name is doctor Tom London. He

0:35:40.719 --> 0:35:43.040
<v Speaker 2>said to me, Shari, if you do the EPI track,

0:35:43.200 --> 0:35:45.759
<v Speaker 2>you will always be an epidemiologist. That is what you're

0:35:45.800 --> 0:35:47.960
<v Speaker 2>going to be doing. He said, if you do community

0:35:47.960 --> 0:35:50.360
<v Speaker 2>health and prevention and you're going to get EPI, but

0:35:50.400 --> 0:35:52.319
<v Speaker 2>it will open you up and allow you to do

0:35:52.400 --> 0:35:53.960
<v Speaker 2>other things for the rest of your life. And so

0:35:54.840 --> 0:35:57.359
<v Speaker 2>that's what I did. And I guess another thing that

0:35:57.400 --> 0:35:59.960
<v Speaker 2>I'm incredibly grateful for over the years are the men

0:36:00.080 --> 0:36:02.040
<v Speaker 2>tours that I've had, and they've helped me make some

0:36:02.120 --> 0:36:03.560
<v Speaker 2>really difficult decisions.

0:36:04.280 --> 0:36:06.920
<v Speaker 1>So can you talk about how you went from grad

0:36:06.960 --> 0:36:10.440
<v Speaker 1>school to the Hepatitis B Foundation? What was that experience?

0:36:10.520 --> 0:36:13.879
<v Speaker 2>Like my experience might be a little bit unusual in

0:36:13.920 --> 0:36:17.319
<v Speaker 2>that I started somewhere I never left. So when you

0:36:17.360 --> 0:36:20.520
<v Speaker 2>get your MPH degree, you have to part of the

0:36:20.600 --> 0:36:24.320
<v Speaker 2>training is to complete some kind of research project or practicum.

0:36:24.600 --> 0:36:26.520
<v Speaker 2>You have to go out and practice what you've learned.

0:36:26.880 --> 0:36:30.759
<v Speaker 2>And most schools have now it's online, but when I

0:36:30.840 --> 0:36:33.200
<v Speaker 2>was there it could because I'm old. It was a binder, right.

0:36:33.239 --> 0:36:35.920
<v Speaker 2>So most schools have a list of organizations that you

0:36:35.960 --> 0:36:39.160
<v Speaker 2>can look at to do your research project, and the

0:36:39.160 --> 0:36:42.680
<v Speaker 2>Hepatitis B Foundation was listed in the Temple book, and

0:36:42.760 --> 0:36:45.319
<v Speaker 2>I said, oh, you know, I did a little bit

0:36:45.320 --> 0:36:48.280
<v Speaker 2>of research on it. And I always have been interested

0:36:48.320 --> 0:36:50.359
<v Speaker 2>in infectious diseases, even when I was in the lab.

0:36:50.400 --> 0:36:52.719
<v Speaker 2>I worked on infectious disease. I worked on cancer and

0:36:52.760 --> 0:36:55.040
<v Speaker 2>with hepatitis B. I was like, well, you've got both.

0:36:55.080 --> 0:36:57.319
<v Speaker 2>You've got the infectious disease component and you've got the

0:36:57.360 --> 0:37:01.520
<v Speaker 2>cancer component. So I just gave them a call. I

0:37:01.600 --> 0:37:04.759
<v Speaker 2>was halfway through my MPH program and I said, I

0:37:04.840 --> 0:37:07.480
<v Speaker 2>need to do a research project. Would you be interested

0:37:07.560 --> 0:37:10.400
<v Speaker 2>in having an intern? And I wound up doing my

0:37:10.440 --> 0:37:13.600
<v Speaker 2>research project there, and when I graduated a year later,

0:37:14.040 --> 0:37:15.800
<v Speaker 2>they said to me, well, why don't you just stay.

0:37:16.239 --> 0:37:18.200
<v Speaker 2>Let's see what we can do. We don't have a

0:37:18.200 --> 0:37:20.359
<v Speaker 2>public health program. Maybe you can help us build one.

0:37:20.440 --> 0:37:23.720
<v Speaker 2>And that was in two thousand and I just never left.

0:37:24.040 --> 0:37:27.680
<v Speaker 1>That's amazing. I love that. And so with a degree

0:37:27.680 --> 0:37:29.959
<v Speaker 1>in public health, like we've both said, you can do

0:37:30.040 --> 0:37:32.840
<v Speaker 1>so many different things, and there are so many different

0:37:32.880 --> 0:37:36.120
<v Speaker 1>places or types of places you can work, right, you

0:37:36.160 --> 0:37:39.000
<v Speaker 1>can work in academia, you can work for the government,

0:37:39.040 --> 0:37:41.960
<v Speaker 1>you can work in industry, you can work for nonprofit

0:37:42.320 --> 0:37:44.719
<v Speaker 1>and so can you talk a little bit about what

0:37:44.840 --> 0:37:47.799
<v Speaker 1>some of the pros and cons are of the nonprofit

0:37:47.840 --> 0:37:50.920
<v Speaker 1>world and some of the general ways that it differs

0:37:51.080 --> 0:37:55.560
<v Speaker 1>from academic, government or industry careers. In public health.

0:37:56.440 --> 0:37:59.440
<v Speaker 2>Sure, So in the no I think the nonprofit world

0:37:59.480 --> 0:38:03.160
<v Speaker 2>has pros and it has cons I think we have

0:38:03.239 --> 0:38:08.520
<v Speaker 2>the flexibility of setting our own strategic plan and being

0:38:08.560 --> 0:38:10.719
<v Speaker 2>on the ground and doing what we want to do

0:38:10.800 --> 0:38:12.480
<v Speaker 2>and what we know needs to get done, and we

0:38:12.520 --> 0:38:14.719
<v Speaker 2>can do it with very little red tape. You know,

0:38:14.760 --> 0:38:18.239
<v Speaker 2>we're small organizations for the most part. We don't have

0:38:18.320 --> 0:38:21.560
<v Speaker 2>the same kind of policies and red tape that you

0:38:21.680 --> 0:38:26.960
<v Speaker 2>might see in large academic institutions or in government entities.

0:38:27.040 --> 0:38:29.960
<v Speaker 2>You know, when we if on Monday we realize that

0:38:30.040 --> 0:38:32.239
<v Speaker 2>something is important to do, we can plan it on

0:38:32.280 --> 0:38:34.719
<v Speaker 2>Tuesday and do it on Wednesday. We don't really have to.

0:38:35.040 --> 0:38:36.839
<v Speaker 2>We don't have to go through the same kind of

0:38:37.040 --> 0:38:41.400
<v Speaker 2>processes that other organizations do. I also think a problem

0:38:41.520 --> 0:38:44.120
<v Speaker 2>for nonprofits, of course, is funding. Right. We are always

0:38:44.200 --> 0:38:46.160
<v Speaker 2>chasing the dollars and trying to make sure that we

0:38:46.239 --> 0:38:48.720
<v Speaker 2>have enough funding, and we will never have enough funding.

0:38:48.960 --> 0:38:50.839
<v Speaker 2>So it's about you know, what kind of funding can

0:38:50.880 --> 0:38:53.680
<v Speaker 2>you can you get to make sure you're meeting your

0:38:53.719 --> 0:38:58.520
<v Speaker 2>mission and how do you spend it in the wisest way. So,

0:38:58.640 --> 0:39:01.480
<v Speaker 2>of course, you know, for the dollars is always very

0:39:01.560 --> 0:39:05.280
<v Speaker 2>very difficult. So I think also in the nonprofit world,

0:39:05.320 --> 0:39:08.000
<v Speaker 2>we think about who our stakeholders are, and that's how

0:39:08.040 --> 0:39:10.759
<v Speaker 2>we work towards our mission. So, for example, I have

0:39:10.800 --> 0:39:13.239
<v Speaker 2>to answer to a board of directors, I have to

0:39:13.280 --> 0:39:15.520
<v Speaker 2>answer to my funders, and then of course we have

0:39:15.560 --> 0:39:18.200
<v Speaker 2>to answer to our constituents, the people who we're trying

0:39:18.239 --> 0:39:21.080
<v Speaker 2>to meet their needs, and the people who our mission

0:39:21.160 --> 0:39:24.560
<v Speaker 2>is for. And so because my stakeholders are different than

0:39:24.960 --> 0:39:29.319
<v Speaker 2>the CDC stakeholders or Druxtel University stakeholders, you know, I

0:39:29.360 --> 0:39:32.080
<v Speaker 2>think it impacts how you can get your work done.

0:39:32.560 --> 0:39:35.239
<v Speaker 2>I think that being in the nonprofit world does give

0:39:35.320 --> 0:39:39.360
<v Speaker 2>us the flexibility for those kinds of partnerships. And you know,

0:39:39.480 --> 0:39:41.799
<v Speaker 2>the one thing I love about us as a nonprofit

0:39:41.960 --> 0:39:44.359
<v Speaker 2>is we're neutral, so we can play with everyone, right.

0:39:44.400 --> 0:39:49.680
<v Speaker 2>We can partner with government agencies and multiple academic institutions

0:39:49.719 --> 0:39:55.160
<v Speaker 2>and multiple researchers, and pharmaceutical industry and other corporations, and

0:39:55.200 --> 0:39:58.400
<v Speaker 2>we remain neutral throughout, which makes that's a strength for

0:39:58.520 --> 0:40:01.960
<v Speaker 2>us because it means that others feel safe partnering with

0:40:02.080 --> 0:40:04.760
<v Speaker 2>us too, and we can sometimes bring groups of people

0:40:04.760 --> 0:40:07.520
<v Speaker 2>together that others can't because we have no skin in

0:40:07.520 --> 0:40:07.839
<v Speaker 2>the game.

0:40:08.800 --> 0:40:11.719
<v Speaker 1>So we get a lot of listeners who are interested

0:40:11.760 --> 0:40:14.920
<v Speaker 1>in the field of public health but don't know maybe

0:40:14.960 --> 0:40:18.399
<v Speaker 1>how to get started or what options are available to them.

0:40:18.640 --> 0:40:20.960
<v Speaker 1>And so I wanted to ask you what one piece

0:40:21.000 --> 0:40:23.800
<v Speaker 1>of advice is that you would give to someone who's

0:40:23.840 --> 0:40:24.959
<v Speaker 1>in this boat.

0:40:25.600 --> 0:40:29.480
<v Speaker 2>Oh. I think your best bet is to find a

0:40:29.480 --> 0:40:32.279
<v Speaker 2>couple of people and email them. Reach out, find a

0:40:32.320 --> 0:40:35.759
<v Speaker 2>few exciting people who you know, you find maybe online

0:40:36.040 --> 0:40:39.279
<v Speaker 2>or maybe you find them at an academic institution, go

0:40:39.320 --> 0:40:42.160
<v Speaker 2>on their web page, and just email them or call them.

0:40:42.600 --> 0:40:46.600
<v Speaker 2>I have found in doing this myself public health practitioners

0:40:46.640 --> 0:40:49.480
<v Speaker 2>are really open and want to share this kind of information.

0:40:50.440 --> 0:40:51.879
<v Speaker 2>So I mean, I could tell you to go take

0:40:51.920 --> 0:40:53.560
<v Speaker 2>a course and see if you like it, but that's

0:40:53.560 --> 0:40:55.640
<v Speaker 2>only going to give you one piece of the pie,

0:40:55.680 --> 0:40:58.400
<v Speaker 2>and it also is expensive. So I think talking to

0:40:58.440 --> 0:41:00.760
<v Speaker 2>people it's the best thing you can do.

0:41:00.760 --> 0:41:03.920
<v Speaker 1>Do you have any personal public health heroes?

0:41:04.880 --> 0:41:09.320
<v Speaker 2>Oh? I love that question. Yeah, And I think the

0:41:09.400 --> 0:41:11.799
<v Speaker 2>first person that brings to mind is doctor Sue Wong.

0:41:12.600 --> 0:41:15.840
<v Speaker 2>She is an absolute hero of mine. She is a

0:41:16.040 --> 0:41:19.360
<v Speaker 2>mom and a wife and a public health professional and

0:41:19.480 --> 0:41:22.719
<v Speaker 2>a doctor and a person living with hepatatus be and

0:41:23.640 --> 0:41:26.800
<v Speaker 2>also the outgoing president of the World Hepatitis Alliance. I

0:41:26.920 --> 0:41:29.440
<v Speaker 2>think she must find forty eight hours a day somehow.

0:41:29.440 --> 0:41:31.600
<v Speaker 2>I don't know how she does it, but she she

0:41:31.800 --> 0:41:35.640
<v Speaker 2>is a hero of mine who very courageously and loudly

0:41:36.120 --> 0:41:39.600
<v Speaker 2>shouts to the world but the need for hepatatus be

0:41:39.880 --> 0:41:42.359
<v Speaker 2>treatment and cure. But she does it in a way

0:41:42.520 --> 0:41:46.359
<v Speaker 2>that's loving and welcoming and just so brave. I love her.

0:41:46.760 --> 0:41:49.480
<v Speaker 1>Oh, I love that so much. That's such a good answer.

0:41:50.400 --> 0:41:53.080
<v Speaker 1>So what do you hope this next year brings in

0:41:53.239 --> 0:41:56.279
<v Speaker 1>terms of hepatitis, be research or awareness.

0:41:57.320 --> 0:42:00.319
<v Speaker 2>We have some really exciting things happening at the end

0:42:00.440 --> 0:42:04.640
<v Speaker 2>of twenty twenty one. The ACIP, which I know everyone

0:42:04.680 --> 0:42:07.279
<v Speaker 2>in the US now knows the ACIP because of the

0:42:07.480 --> 0:42:12.920
<v Speaker 2>COVID nineteen vaccination. So the ACIP recently approved and CDC

0:42:13.200 --> 0:42:17.920
<v Speaker 2>is signing off on universal adult Hepatitis B vaccine guidelines,

0:42:18.000 --> 0:42:20.920
<v Speaker 2>and that means that for the next year we are

0:42:21.040 --> 0:42:24.560
<v Speaker 2>working really hard to implement those And that means that

0:42:24.719 --> 0:42:29.160
<v Speaker 2>right now, so previously people were recommended to get vaccinated

0:42:29.200 --> 0:42:31.320
<v Speaker 2>for het B in the US when they were born

0:42:32.239 --> 0:42:34.320
<v Speaker 2>or if they were in a particular risk group. And

0:42:34.400 --> 0:42:37.279
<v Speaker 2>what that means is that only twenty five percent of

0:42:37.360 --> 0:42:40.399
<v Speaker 2>people in the US are protected against heb B. Now

0:42:40.600 --> 0:42:43.760
<v Speaker 2>the ACIP is recommending that all adults between the ages

0:42:43.800 --> 0:42:46.799
<v Speaker 2>of eighteen and fifty nine nineteen and fifty nine get vaccinated,

0:42:47.440 --> 0:42:49.880
<v Speaker 2>which is going to give us a huge opportunity to

0:42:50.000 --> 0:42:52.920
<v Speaker 2>protect people. So we are very excited for the next

0:42:52.920 --> 0:42:55.080
<v Speaker 2>twelve months to implement this, and now we have to

0:42:55.160 --> 0:42:57.240
<v Speaker 2>make it happen, right because the policy is on paper,

0:42:57.520 --> 0:43:00.439
<v Speaker 2>now we have to We are charged with making this happen.

0:43:00.640 --> 0:43:03.680
<v Speaker 2>So I am excited about that and I think great

0:43:03.719 --> 0:43:05.399
<v Speaker 2>things will happen with it over the next year.

0:43:24.280 --> 0:43:28.240
<v Speaker 1>Well, that was simply wonderful. Thank you so much, doctor

0:43:28.280 --> 0:43:30.920
<v Speaker 1>Cohen for taking the time to chat today. If you

0:43:31.000 --> 0:43:34.319
<v Speaker 1>want to learn more about the Hepatitis B Foundation, check

0:43:34.360 --> 0:43:37.239
<v Speaker 1>out HEPB dot org and I'll also link to the

0:43:37.320 --> 0:43:40.040
<v Speaker 1>website and include social media links on our post for

0:43:40.200 --> 0:43:44.400
<v Speaker 1>this episode. Speaking of our website. On our website you

0:43:44.520 --> 0:43:47.680
<v Speaker 1>can find all kinds of good stuff, like the sources

0:43:47.760 --> 0:43:51.840
<v Speaker 1>for all of our episodes, transcripts, quarantining and Placeberrita recipes,

0:43:52.200 --> 0:43:55.960
<v Speaker 1>our bookshop dot org affiliate account, links to music by Bloodmobile,

0:43:56.000 --> 0:43:59.080
<v Speaker 1>who is now on Spotify, links to merch and our Patreon,

0:43:59.160 --> 0:44:03.560
<v Speaker 1>alcohol free eppes and so much more. Thanks as always

0:44:03.640 --> 0:44:06.560
<v Speaker 1>to Bloodmobile for providing the music for this episode and

0:44:06.800 --> 0:44:09.719
<v Speaker 1>all of our episodes. And thank you to you listeners.

0:44:10.120 --> 0:44:12.520
<v Speaker 1>I hope that you liked this deeper dive into het

0:44:12.600 --> 0:44:16.640
<v Speaker 1>Be And of course a big shout out to our wonderful,

0:44:16.920 --> 0:44:20.080
<v Speaker 1>thoughtful patrons. We love you and appreciate you so much.

0:44:21.120 --> 0:44:23.480
<v Speaker 1>We have got a brand new episode coming out next

0:44:23.520 --> 0:44:27.080
<v Speaker 1>week on a whole new topic, so until then, keep

0:44:27.280 --> 0:44:28.120
<v Speaker 1>washing those hands.